Skip to Content

Prognostic factors for patients with brain metastases – after whole brain radiotherapy

In this MEDtalk, Olav Yri, MD, Post doc., PhD, Department of Oncology, Oslo University Hospital presents data from a population-based prospective observational study at four hospitals in Norway. The patients who were included in the study were newly diagnosed with brain metastases from solid cancers and they were treated with whole brain radiotherapy.

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top